Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US-12061183-B2 · Aug 13, 2024 · US
Foss Willard is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Foss Willard |
| Total patents | 16 |
| First publication | Jun 11, 2015 |
| Latest publication | Aug 13, 2024 |
Publications ranked by popularity score, then publication date.
US-12061183-B2 · Aug 13, 2024 · US
US-2023243806-A1 · Aug 3, 2023 · US
US-11320416-B1 · May 3, 2022 · US
US-10900951-B1 · Jan 26, 2021 · US
US-2020407681-A1 · Dec 31, 2020 · US
US-10705070-B1 · Jul 7, 2020 · US
US-2020206212-A1 · Jul 2, 2020 · US
US-10555912-B2 · Feb 11, 2020 · US
US-10527604-B1 · Jan 7, 2020 · US
US-2019247357-A1 · Aug 15, 2019 · US
Latest publications not already listed above.
US-2019054033-A1 · Feb 21, 2019 · US
US-10076501-B2 · Sep 18, 2018 · US
US-2017224627-A1 · Aug 10, 2017 · US
US-9585960-B2 · Mar 7, 2017 · US
US-2016137980-A1 · May 19, 2016 · US
US-2015157722-A1 · Jun 11, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Abraxis Bioscience Llc | 13 |
| Celgene Corp | 2 |
| Anthrogenesis Corp | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/337 | 9 |
| A61P35/00 | 8 |
| A61K9/19 | 8 |
| A61K9/0019 | 8 |
| A61K47/26 | 7 |